Skip to main content
Top
Published in: Diabetologia 2/2010

01-02-2010 | Article

Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study

Authors: N. D. Palmer, C. D. Langefeld, J. T. Ziegler, F. Hsu, S. M. Haffner, T. Fingerlin, J. M. Norris, Y. I. Chen, S. S. Rich, T. Haritunians, K. D. Taylor, R. N. Bergman, J. I. Rotter, D. W. Bowden

Published in: Diabetologia | Issue 2/2010

Login to get access

Abstract

Aims/hypothesis

The majority of type 2 diabetes genome-wide association studies (GWAS) to date have been performed in European-derived populations and have identified few variants that mediate their effect through insulin resistance. The aim of this study was to evaluate two quantitative, directly assessed measures of insulin resistance, namely insulin sensitivity index (SI) and insulin disposition index (DI), in Hispanic-American participants using an agnostic, high-density single nucleotide polymorphism (SNP) scan, and to validate these findings in additional samples.

Methods

A two-stage GWAS was performed in Hispanic-American samples from the Insulin Resistance Atherosclerosis Family Study. In Stage 1, 317,000 SNPs were assessed using 229 DNA samples. SNPs with evidence of association with glucose homeostasis and adiposity traits were then genotyped on the entire set of Hispanic-American samples (n = 1,190). This report focuses on the glucose homeostasis traits: SI and DI.

Results

Although evidence of association did not reach genome-wide significance (p = 5 × 10−7), in the combined analysis SNPs had admixture-adjusted p values of p ADD = 0.00010–0.0020 with 8 to 41% differences in genotypic means for SI and DI.

Conclusions/interpretation

Several candidate loci were identified that are nominally associated with SI and/or DI in Hispanic-American participants. Replication of these findings in independent cohorts and additional focused analysis of these loci is warranted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678CrossRef Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678CrossRef
2.
go back to reference Saxena R, Voight BF, Lyssenko V et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331–1336CrossRefPubMed Saxena R, Voight BF, Lyssenko V et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331–1336CrossRefPubMed
3.
go back to reference Scott LJ, Mohlke KL, Bonnycastle LL et al (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341–1345CrossRefPubMed Scott LJ, Mohlke KL, Bonnycastle LL et al (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341–1345CrossRefPubMed
4.
go back to reference Sladek R, Rocheleau G, Rung J et al (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881–885CrossRefPubMed Sladek R, Rocheleau G, Rung J et al (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881–885CrossRefPubMed
5.
go back to reference Steinthorsdottir V, Thorleifsson G, Reynisdottir I et al (2007) A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39:770–775CrossRefPubMed Steinthorsdottir V, Thorleifsson G, Reynisdottir I et al (2007) A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39:770–775CrossRefPubMed
6.
go back to reference Zeggini E, Weedon MN, Lindgren CM et al (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336–1341CrossRefPubMed Zeggini E, Weedon MN, Lindgren CM et al (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336–1341CrossRefPubMed
7.
go back to reference Hayes MG, Pluzhnikov A, Miyake K et al (2007) Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies. Diabetes 56:3033–3044CrossRefPubMed Hayes MG, Pluzhnikov A, Miyake K et al (2007) Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies. Diabetes 56:3033–3044CrossRefPubMed
8.
go back to reference Lewis JP, Palmer ND, Hicks PJ et al (2008) Association analysis of European-derived type 2 diabetes SNPs from whole genome association studies in African Americans. Diabetes 57:2220–2225CrossRefPubMed Lewis JP, Palmer ND, Hicks PJ et al (2008) Association analysis of European-derived type 2 diabetes SNPs from whole genome association studies in African Americans. Diabetes 57:2220–2225CrossRefPubMed
9.
go back to reference Palmer ND, Goodarzi MO, Langefeld CD et al (2008) Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study. Diabetes 57:1093–1100CrossRefPubMed Palmer ND, Goodarzi MO, Langefeld CD et al (2008) Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study. Diabetes 57:1093–1100CrossRefPubMed
10.
go back to reference Bergman RN, Ader M, Huecking K, van Citters G (2002) Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 51(Suppl 1):S212–S220CrossRefPubMed Bergman RN, Ader M, Huecking K, van Citters G (2002) Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 51(Suppl 1):S212–S220CrossRefPubMed
11.
go back to reference DeFronzo RA (1988) Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667–687PubMed DeFronzo RA (1988) Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667–687PubMed
12.
go back to reference Haffner SM, D'Agostino R, Saad MF et al (1996) Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 45:742–748CrossRefPubMed Haffner SM, D'Agostino R, Saad MF et al (1996) Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 45:742–748CrossRefPubMed
13.
go back to reference Haffner SM, Howard G, Mayer E et al (1997) Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 46:63–69CrossRefPubMed Haffner SM, Howard G, Mayer E et al (1997) Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 46:63–69CrossRefPubMed
14.
go back to reference Muoio DM, Newgard CB (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9:193–205CrossRefPubMed Muoio DM, Newgard CB (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9:193–205CrossRefPubMed
15.
go back to reference Rich SS, Goodarzi MO, Palmer ND et al (2009) A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS FS). Diabetologia 52:1326–1333CrossRefPubMed Rich SS, Goodarzi MO, Palmer ND et al (2009) A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS FS). Diabetologia 52:1326–1333CrossRefPubMed
16.
go back to reference Norris JM, Langefeld CD, Talbert ME et al (2009) Genome-wide association study and follow-up analysis of adiposity traits in Hispanic Americans: The IRAS Family Study. Obesity (Silver Spring) 17:1932–1941CrossRef Norris JM, Langefeld CD, Talbert ME et al (2009) Genome-wide association study and follow-up analysis of adiposity traits in Hispanic Americans: The IRAS Family Study. Obesity (Silver Spring) 17:1932–1941CrossRef
17.
go back to reference Henkin L, Bergman RN, Bowden DW et al (2003) Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann Epidemiol 13:211–217CrossRefPubMed Henkin L, Bergman RN, Bowden DW et al (2003) Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann Epidemiol 13:211–217CrossRefPubMed
18.
go back to reference Pacini G, Bergman RN (1986) MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23:113–122CrossRefPubMed Pacini G, Bergman RN (1986) MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23:113–122CrossRefPubMed
19.
go back to reference Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6:45–86CrossRefPubMed Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6:45–86CrossRefPubMed
20.
go back to reference Bergman RN, Ider YZ, Bowden CR, Cobelli C (1979) Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667–E677PubMed Bergman RN, Ider YZ, Bowden CR, Cobelli C (1979) Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667–E677PubMed
21.
go back to reference Steil GM, Volund A, Kahn SE, Bergman RN (1993) Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes 42:250–256CrossRefPubMed Steil GM, Volund A, Kahn SE, Bergman RN (1993) Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes 42:250–256CrossRefPubMed
22.
go back to reference Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155:945–959PubMed Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155:945–959PubMed
23.
go back to reference Rich SS, Bowden DW, Haffner SM et al (2005) A genome scan for fasting insulin and fasting glucose identifies a quantitative trait locus on chromosome 17p: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes 54:290–295CrossRefPubMed Rich SS, Bowden DW, Haffner SM et al (2005) A genome scan for fasting insulin and fasting glucose identifies a quantitative trait locus on chromosome 17p: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes 54:290–295CrossRefPubMed
24.
go back to reference Rich SS, Bowden DW, Haffner SM et al (2004) Identification of quantitative trait loci for glucose homeostasis: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 53:1866–1875CrossRefPubMed Rich SS, Bowden DW, Haffner SM et al (2004) Identification of quantitative trait loci for glucose homeostasis: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 53:1866–1875CrossRefPubMed
25.
go back to reference Gunderson KL, Steemers FJ, Ren H et al (2006) Whole-genome genotyping. Methods Enzymol 410:359–376CrossRefPubMed Gunderson KL, Steemers FJ, Ren H et al (2006) Whole-genome genotyping. Methods Enzymol 410:359–376CrossRefPubMed
26.
go back to reference Choudhry S, Coyle NE, Tang H et al (2006) Population stratification confounds genetic association studies among Latinos. Hum Genet 118:652–664CrossRefPubMed Choudhry S, Coyle NE, Tang H et al (2006) Population stratification confounds genetic association studies among Latinos. Hum Genet 118:652–664CrossRefPubMed
27.
go back to reference Seldin MF, Tian C, Shigeta R et al (2007) Argentine population genetic structure: large variance in Amerindian contribution. Am J Phys Anthropol 132:455–462CrossRefPubMed Seldin MF, Tian C, Shigeta R et al (2007) Argentine population genetic structure: large variance in Amerindian contribution. Am J Phys Anthropol 132:455–462CrossRefPubMed
28.
go back to reference International HapMap Consortium (2003) The International HapMap Project. Nature 426:789–796CrossRef International HapMap Consortium (2003) The International HapMap Project. Nature 426:789–796CrossRef
29.
go back to reference Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265CrossRefPubMed Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265CrossRefPubMed
30.
go back to reference O'Connell JR, Weeks DE (1998) PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63:259–266CrossRefPubMed O'Connell JR, Weeks DE (1998) PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63:259–266CrossRefPubMed
31.
go back to reference Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198–1211CrossRefPubMed Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198–1211CrossRefPubMed
32.
go back to reference Bergman RN, Finegood DT, Kahn SE (2002) The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 32(Suppl 3):35–45CrossRefPubMed Bergman RN, Finegood DT, Kahn SE (2002) The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 32(Suppl 3):35–45CrossRefPubMed
33.
go back to reference Kim SP, Catalano KJ, Hsu IR, Chiu JD, Richey JM, Bergman RN (2007) Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia. Am J Physiol Endocrinol Metab 292:E1590–E1598CrossRefPubMed Kim SP, Catalano KJ, Hsu IR, Chiu JD, Richey JM, Bergman RN (2007) Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia. Am J Physiol Endocrinol Metab 292:E1590–E1598CrossRefPubMed
34.
go back to reference Saad MF, Anderson RL, Laws A et al (1994) A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes 43:1114–1121CrossRefPubMed Saad MF, Anderson RL, Laws A et al (1994) A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes 43:1114–1121CrossRefPubMed
35.
go back to reference Bergman RN, Zaccaro DJ, Watanabe RM et al (2003) Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin. Diabetes 52:2168–2174CrossRefPubMed Bergman RN, Zaccaro DJ, Watanabe RM et al (2003) Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin. Diabetes 52:2168–2174CrossRefPubMed
36.
go back to reference Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308:421–424CrossRefPubMed Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308:421–424CrossRefPubMed
37.
go back to reference Arking DE, Pfeufer A, Post W et al (2006) A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 38:644–651CrossRefPubMed Arking DE, Pfeufer A, Post W et al (2006) A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 38:644–651CrossRefPubMed
38.
go back to reference Yamazaki K, McGovern D, Ragoussis J et al (2005) Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 14:3499–3506CrossRefPubMed Yamazaki K, McGovern D, Ragoussis J et al (2005) Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 14:3499–3506CrossRefPubMed
39.
go back to reference McPherson R, Pertsemlidis A, Kavaslar N et al (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316:1488–1491CrossRefPubMed McPherson R, Pertsemlidis A, Kavaslar N et al (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316:1488–1491CrossRefPubMed
40.
go back to reference Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38:209–213CrossRefPubMed Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38:209–213CrossRefPubMed
41.
go back to reference Rampersaud E, Damcott CM, Fu M et al (2007) Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations. Diabetes 56:3053–3062CrossRefPubMed Rampersaud E, Damcott CM, Fu M et al (2007) Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations. Diabetes 56:3053–3062CrossRefPubMed
42.
go back to reference Zeggini E, Scott LJ, Saxena R et al (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638–645CrossRefPubMed Zeggini E, Scott LJ, Saxena R et al (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638–645CrossRefPubMed
Metadata
Title
Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study
Authors
N. D. Palmer
C. D. Langefeld
J. T. Ziegler
F. Hsu
S. M. Haffner
T. Fingerlin
J. M. Norris
Y. I. Chen
S. S. Rich
T. Haritunians
K. D. Taylor
R. N. Bergman
J. I. Rotter
D. W. Bowden
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1586-2

Other articles of this Issue 2/2010

Diabetologia 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.